Michel Alary obtained his M.D. from Université de Sherbrooke in 1974. After eight years of general practice, he redirected his career towards public health. He completed a Ph.D. in epidemiology at Laval University, Quebec, in 1991. After a post-doctoral fellowship with Professor Peter Piot (the co-discoverer of the Ebola virus, and the founding executive director of UNAIDS from 1995 to 2008, and recipient of the Gairdner Global Health Award in 2015) in Antwerp, Belgium, he became professor of epidemiology at Laval University in 1992, and is also involved with the Institut national de santé publique du Québec. Most of his academic career has been devoted to epidemiologic and prevention research on HIV and other sexually transmitted and blood-borne infections among the most vulnerable populations, particularly female sex workers and their male sexual partners in West Africa and India, as well as intravenous drug users and men who have sex with men in Canada.

Michel Alary has obtained funding for 93 research projects for a total of over $75 million, including 64 projects as principal investigator (approximately $50 million). He has published 236 peer-reviewed scientific articles, and over 650 conference abstracts. He has been an invited speaker on 106 occasions. He has produced major reports for the World Bank and UNAIDS on the HIV epidemiologic situation and response towards this epidemic in the most vulnerable populations for all of sub-Saharan Africa. He received the Mark Wainberg Lecturer Award from the Canadian Association for HIV Research in recognition of his outstanding contributions and advocacy in advancing HIV/AIDS research in Canada, and internationally. He also received the Diamond Award for clinical research from the CHU de Québec in 2014 for the excellence of his public health research work in India. He received the 2015 Researcher Emeritus Award from the Quebec network on population health research. In September 2016, he was nominated as a fellow of the Canadian Academy of Health Sciences. He is currently the Director of the Population Health and Optimal Health Practices Research axis in the Centre de recherche du CHU de Québec – Université Laval, which includes over 90 researchers, 200 graduate students, and 175 staff members.

Finally, Michel Alary has been the principle supervisor of over 40 graduate students and postdoctoral fellows, in addition to having acted as co-director or evaluator of an additional 15 graduate students. Almost all these students completed their Master’s or Ph.D. thesis on topics related to global health and approximately 80% of them were from low- and middle-income countries. Most of his research projects also include knowledge transfer components towards communities, clinicians, public health practitioners, and decision-makers.

Hôpital Saint-Sacrement
1050, chemin Sainte-Foy
HSS
H0-02
Québec, Québec
Canada G1S 4L8
288 entries « 1 of 29 »

Leclerc P, Roy É, Morissette C, Alary M, Blouin K

Surveillance des maladies infectieuses chez les utilisateurs de drogues par injection - Épidémiologie du VIH 1995-2018 - Épidémiologie du VHC 2003-2018

Book

Institut national de santé publique du Québec, Montréal, QC, 2021, ISBN: 9782550885764.

Lanièce Delaunay C, Godin A, Kronfli N, Panagiotoglou D, Cox J, Alary M, Klein MB, Maheu-Giroux M

Can hepatitis C elimination targets be sustained among people who inject drugs post-2030?

Journal Article

Int J Drug Policy, 2021.

Abstract | Links:

Drolet M, Laprise JF, Martin D, Jit M, Bénard É, Gingras G, Boily MC, Alary M, Baussano I, Hutubessy R, Brisson M

Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.

Journal Article

Lancet Infect Dis, 2021.

Abstract | Links:

Bazie WW, Boucher J, Vitry J, Goyer B, Routy JP, Tremblay C, Trottier S, Jenabian MA, Provost P, Alary M, Gilbert C

Plasma Extracellular Vesicle Subtypes May be Useful as Potential Biomarkers of Immune Activation in People With HIV.

Journal Article

Pathog Immun, 6 (1), 2021.

Abstract | Links:

Bazie WW, Goyer B, Boucher J, Zhang Y, Planas D, Chatterjee D, Routy JP, Alary M, Ancuta P, Gilbert C

Diurnal Variation of Plasma Extracellular Vesicle Is Disrupted in People Living with HIV.

Journal Article

Pathogens, 10 (5), 2021.

Abstract | Links:

Arum C, Fraser H, Artenie AA, Bivegete S, Trickey A, Alary M, Astemborski J, Iversen J, Lim AG, MacGregor L, Morris M, Ong JJ, Platt L, Sack-Davis R, van Santen DK, Solomon SS, Sypsa V, Valencia J, Van Den Boom W, Walker JG, Ward Z, Stone J, Vickerman P, Cherutich P, Debeck K, Dietze P, Dumchev K, Hayashi K, Hellard M, Hickman M, Hope V, Judd A, Kåberg M, Kurth AE, Leclerc P, Maher L, Mehta SH, Page KA, Prins M, Todd CS, Strathdee SA

Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.

Journal Article

Lancet Public Health, 6 (5), 2021.

Abstract | Links:

Tounkara FK, Teguete I, Guedou FA, Talbot D, Traore CB, Behanzin L, Traore S, Goma-Matsetse E, Aza-Gnandji M, Keita B, Guenoun J, Coutlee F, Alary M

Type-specific incidence, persistence and factors associated with human papillomavirus infection among female sex workers in Benin and Mali, West Africa.

Journal Article

Int J Infect Dis, 106 , 2021.

Abstract | Links:

Silhol R, Geidelberg L, Mitchell KM, Mishra S, Dimitrov D, Bowring A, Behanzin L, Guedou F, Diabate S, Schwartz S, Billong SC, Njindam IM, Levitt D, Mukandavire C, Maheu-Giroux M, Ronn MM, Dalal S, Vickerman P, Baral S, Alary M, Boily MC

Assessing the Potential Impact of Disruptions Due to COVID-19 on HIV Among Key and Lower-Risk Populations in the Largest Cities of Cameroon and Benin.

Journal Article

J Acquir Immune Defic Syndr, 87 (3), 2021.

Abstract | Links:

Geidelberg L, Mitchell KM, Alary M, Mboup A, Behanzin L, Guedou F, Geraldo N, Goma-Matsetse E, Giguere K, Aza-Gnandji M, Kessou L, Diallo M, Keke RK, Bachabi M, Dramane K, Lafrance C, Affolabi D, Diabate S, Gagnon MP, Zannou DM, Gangbo F, Silhol R, Cianci F, Vickerman P, Boily MC

Mathematical Model Impact Analysis of a Real-Life Pre-exposure Prophylaxis and Treatment-As-Prevention Study Among Female Sex Workers in Cotonou, Benin.

Journal Article

J Acquir Immune Defic Syndr, 86 (2), 2021.

Abstract | Links:

Godin A, Kronfli N, Cox J, Alary M, Maheu-Giroux M

The role of prison-based interventions for hepatitis C virus (HCV) micro-elimination among people who inject drugs in Montréal, Canada.

Journal Article

Int J Drug Policy, 88 , 2021.

Abstract | Links:

288 entries « 1 of 29 »
Signaler des ajouts ou des modifications

Active projects

  • Antiretroviral-based HIV prevention and its impact on sexual risk behaviours and HIV/STIs among gay, bisexual and other men who have sex with men: Engage Cohort Study, from 2019-04-01 to 2023-03-31
  • Canadian Immunization Research Network, from 2014-06-01 to 2021-12-31
  • Vers des approches plus efficientes en prévention du VIH et en santé reproductive au travers une approche d’équité en santé: programme de recherche interventionnelle chez les femmes travailleuses du sexe en Afrique de l’Ouest., from 2015-07-01 to 2022-06-30

Recently finished projects

  • Étude de démonstration de la prophylaxie préexposition en prévention de VIH chez les hommes ayant des relations sexuelles avec d'autres hommes au Bénin , from 2019-08-20 to 2020-03-31
  • HIV Prevention for Gay and Bisexual Men : A Multisite Study and Development of New HIV Prevention Interventions, from 2014-11-01 to 2019-10-30
  • Mathematical Modeling and Epidemiology to inform HIV Program Science, from 2015-07-01 to 2020-06-30
  • The National CIHR Hepatisis C Network (NCHCN), from 2015-04-01 to 2020-03-31
Data provided by the Université Laval research projects registery